Sun Pharmaceutical Industries is working toward a complete regulatory resolution for three of its manufacturing facilities that are being reviewed by the US Food and Drug Administration (USFDA). Sun Pharmaceutical has completed way of corrective...
In a remarkable move, Nectar Lifesciences announced the sale of its core active pharmaceutical ingredients (API), formulations and menthol business to Ceph Lifesciences Pvt Ltd, a total consideration of Rs 1,290 crore. The transaction includes a...
In an exclusive interaction with India Pharma Outlook, Nitin Stephen Abel, Senior Director, Terumo Interventional Systems, Terumo India, discusses how India’s shift toward outpatient surgeries is driving medical device manufacturers to reengineer min
According to Lok Sabha Speaker Om Birla, India is quickly establishing itself as a global hub for pharmaceuticals and medical research. In New Delhi, Birla said this at the 7th International Conference of the Innovative Physicians Forum...
Mitsui Chemicals has unveiled a new product—InnoCell, a cell culture microplate with high-performance characteristics, designed with outstanding oxygen permeability, that represents a groundbreaking advancement in scientific research tools...
By introducing the Virtual Simulation-based Pharmaceutical Manufacturing Training Program, which is exclusive for pharmacy students, the Karnataka State Pharmacy Council (KSPC) has made a major advancement in pharmacy education
Alembic Pharmaceuticals has entered into a definitive agreement to acquire UK-based Utility Therapeutics Ltd. for USD 12 million, a strategic expansion into the branded anti-infective space in the United States...
Lyfius Pharma Private Limited, a fully owned step-down subsidiary of Aurobindo Pharma, has announced the resumption of production at its Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh
Jiangsu Recbio Technology Company Limited (02179.HK) signed a licensing cooperation agreement with Biological E. Limited (BE), the Indian vaccine and pharmaceuticals industry leader
Biocon Ltd is seeking regulatory approval for its generic version of Ozempic (semaglutide) to get into Canada's high growth obesity drug market, aiming for a submission date of September 2025. This would allow for a...
, CDSCO.jpg)
